Table 2 Treatment characteristics
RT according to protocol no. (%) | 111 (94.1) |
|---|---|
Interval between end of RT and surgery median/range (days) | 3/3 - 10 |
Type of surgery no. (%) | |
LAR | 81 (68.6) |
APR | 35 (29.7) |
Local excision | 1 (0.8) |
No surgery | 1 (0.8) |
Protective stoma after LAR | 72 (87.8) |
Pathological tumor stage no. (%) | |
pT1 | 8 (6.8) |
pT2 | 34 (28.8) |
pT3 | 74 (62.7) |
pT4 | 1 (0.8) |
Pathological nodal stage no. (%) | |
Node negative | 64 (54.2) |
Node positive | 53 (44.9) |
Pathological UICC stage no. (%) | |
I | 32 (27.1) |
II | 30 (25.4) |
III | 44 (37.3) |
IV | 11 (9.3) |
Resection status no. (%) | |
R0 | 104 (88.1) |
R1 (all local) | 6 (5.1) |
R2 (all systemic) | 4 (3.4) |
Unknown | 3 (2.5) |
Number of removed lymph nodes Median/range | 12/1-30 |
Indication for chemotherapy no. (%) | 81 (68.6) |
Actually performed chemotherapy no. (%) | 61 (75.3) |
5-FU & LV chemotherapy | 35 (57.4) |
FOLFOX4 | 15 (24.6) |
others | 11 (18) |